Our team has successfully identified a new class of antibiotic compounds
Our team has successfully identified a new class of antibiotic compounds that demonstrate strong activity against multi-drug resistant bacteria. Early results show promise for clinical development, paving the way for novel treatments in the fight against AMR.
Our team has successfully identified a new class of antibiotic compounds that demonstrate strong activity against multi-drug resistant bacteria. Early results show promise for clinical development, paving the way for novel treatments in the fight against AMR.
Save the date! The Ineos Oxford Institute will host its Annual AMR Conference on November 12–14, 2025, at the University of Oxford.